Gloria Eden Domingo
Family Medicine · Waipahu, HINPI 1205130655
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 132 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 15 manufacturers reported payments, led by Amarin Pharma, Inc. at 25.3% of the total. Reporting peaked in 2021 at $718 and has fallen 59.0% since, to $295 in 2025.
Across 132 payments — averaging $21.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amarin Pharma, Inc.$720
- AstraZeneca$403
- Novo Nordisk$300
- Bayer$281
- E.r. Squibb & Sons, L.L.C.$277
- GSK$219
- plus $650 from 9 others
What the payments were for
- Food & beverage$2,850100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amarin Pharma, Inc. | 29 | $720 |
| AstraZeneca | 21 | $403 |
| Novo Nordisk | 19 | $300 |
| Bayer | 13 | $281 |
| E.r. Squibb & Sons, L.L.C. | 13 | $277 |
| GSK | 9 | $219 |
| Boehringer Ingelheim | 8 | $194 |
| Amgen | 6 | $130 |
| Sanofi-aventis U.S. LLC | 2 | $106 |
| Lilly USA, LLC | 4 | $71 |
| Kowa Pharmaceuticals America, Inc. | 4 | $65 |
| Esperion Therapeutics, Inc. | 1 | $26 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
| Novartis | 1 | $19 |
| Pfizer | 1 | $17 |
How this compares
$2,850 in reported general payments places this provider in the 85th percentile of 376 family medicine providers in Hawaii.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TradjentaLinagliptin | 116 | $152,025 |
| JardianceEmpagliflozin | 52 | $77,132 |
| VascepaIcosapent Ethyl | 68 | $60,631 |
| EliquisApixaban | 41 | $60,154 |
| ProliaDenosumab | 28 | $50,140 |
| JanuviaSitagliptin Phosphate | 25 | $30,880 |
| RybelsusSemaglutide | 19 | $26,967 |
| FarxigaDapagliflozin Propanediol | 16 | $22,234 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 11 | $20,766 |
| Atorvastatin Calcium | 558 | $6,391 |
| SymbicortBudesonide/Formoterol Fumarate | 23 | $6,337 |
| Losartan Potassium | 519 | $5,197 |
| ShingrixVaricella-Zoster Ge/As01b/Pf | 19 | $4,008 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 29 | $3,351 |
| Wixela InhubFluticasone Propion/Salmeterol | 20 | $3,241 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimTradjenta, Jardiance | $194 | $229,157168 claims |
| PfizerEliquis | $17 | $60,15441 claims |
| AmgenProlia | $130 | $50,14028 claims |
| AstraZenecaFarxiga, Symbicort | $403 | $28,57139 claims |
| Novo NordiskRybelsus | $300 | $26,96719 claims |
| GSKTrelegy Ellipta, Shingrix | $219 | $24,77430 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 376 family medicine providers in Hawaii.
Other family medicine in Waipahu
- Edward AlqueroWaipahu$24K
- Noelani HobbsWaipahu$23K
- Judith HernaezWaipahu$7K
- Brian StolleyKihei$126K
- Vicente RamoHonolulu$34K
- Rainier Dennis BautistaLihue$23K
- Choon YeoHonolulu$20K
- Buddy FesterlingHilo$20K
- Roy KogaHilo$20K
- Stuart LernerKailua$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.